Accelerate Diagnostics Sees Prelim. Q4 Sales $3.3M vs $3.92M Est., FY21 Sales $11.8M vs $12.28M Est.

Accelerate Diagnostics Sees Prelim. Q4 Sales $3.3M vs $3.92M Est., FY21 Sales $11.8M vs $12.28M Est.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsGuidance
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!